HCRT and Alzheimer disease: Urrestarazu and Iriarte (2016) speculated that AD patients suffer from some disturbances in the secretion of orexins which brought about sleep disorders, subsequently enhanced amyloid-β level, ultimately contribute to the pathogenesis of the AD.